Adenosine A2A Receptor (Human) Cell Binding Assay, HEK293/Adenosine A2A Receptor-based

CAT#: ITS-1122-LX57
Target Cell Organism: Human
Target Cell Alternative Name: HEK293
Target Cell Name: HEK293/Adenosine A2A Receptor (Human)
Assay Type: Cell Binding Assay
Assay Overview
This assay is used to validate the binding affinity of Adenosine A2A Receptor (Human) binding molecules (such as anti-Adenosine A2A Receptor antibody, ADC) in a cellular context. The assay will be customized according to the client's specific requirements. Please contact our scientists to discuss more details.
Features
Customized to client's specific requirements
Target Cell Name
HEK293/Adenosine A2A Receptor (Human)
Target Cell Organism
Human
Target Cell Background
Creative Biolabs has developed several immune checkpoint stable cell Lines expressing the most popular immune checkpoints to accelerate clients' immunotherapy discovery and clinical translation. Adenosine A2a receptor (A2aR or ADORA2A) stably expressed in HEK-293 cells. Which can be used in binding assays and functional assay.
Target Cell Alternative Name
HEK293
Related Diseases
Cancer
Research Area
Oncology
Assay Name
In Vitro Cell Binding Assay
Short Description
Useful for validating the binding affinity of Adenosine A2A Receptor (Human) binding molecules (such as anti-Adenosine A2A Receptor antibody, ADC) in a cellular context.
Assay Description
Cell-based binding assay is one of most commonly used assays for drug discovery and screening. Creative Biolabs provides In Vitro Adenosine A2A Receptor (Human) Cell Binding Assay to validate the binding affinity of 4-1BB (Human) binding molecules (such as anti-4-59BB antibody, ADC) by cell-based ELISA or cell-based FACS analysis. The assay will be customized according to the client's specific requirements. Please contact our scientists to discuss more details.
Assay Alternative Names
Cell-based Binding Assay; Cell-based ELSA Binding; Cell-based FACS Binding
Assay Type
Cell Binding Assay
Assay Type Details
Validating the binding affinity of Adenosine A2A Receptor (Human) binding molecules (such as anti-Adenosine A2A Receptor antibody, ADC) by cell-based ELISA or cell-based FACS analysis.
Assay MOA
Creative have developed the stable cell line HEK293/Adenosine A2A Receptor (Human), which is designed for validating the binding affinity of Adenosine A2A Receptor (Human) binding molecules (such as anti-Adenosine A2A Receptor antibody, ADC) by cell-based ELISA or cell-based FACS analysis.
For Research Use Only | Not For Clinical Use
Online Inquiry